Connect with us
Holger Rune’s Achilles rehab is now about performance, yet a No. 102 ranking makes his first week back the hard week.
Rubicon Research grew Q1 FY27 sales 51.6% and raised margin guidance, as specialty mix and a cheap New Jersey plant test an expensive post-IPO bet.